Directory

>

Pietro Taverna

avatar

Pietro Taverna

Vice President Research & Translational Medicine | Karyopharm Therapeutics Inc.

Waltham, Massachusetts, United States

View contact details (it's free)

Pietro Taverna

Summary

Pietro Taverna is a distinguished Vice President of Research & Translational Medicine, with extensive expertise in the biopharmaceutical sector, particularly in oncology and translational research. He has a proven track record of leading cross-functional teams through all phases of drug development, from discovery to late-stage clinical trials. His collaborative approach has fostered significant partnerships within the academic and industrial landscapes, enhancing drug development processes. Pietro is highly regarded for his strategic insights in pharmacology and biomarker discovery, and has contributed to numerous publications in prestigious journals. His leadership has driven innovation in translational medicine, particularly in the development of therapies for hematologic malignancies. With a strong educational background in pharmacology, he combines scientific rigor with practical experience to advance therapeutic solutions. Beyond his professional achievements, he has received notable fellowships, underscoring his commitment to excellence in research.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Immigrant

Professional interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Corporate Experience

Pietro Taverna

Work Experience

company logo

Vice President Research & Translational Medicine at

Karyopharm Therapeutics Inc.

February 2023 - Present

company logo

Executive Director, Translational Sciences at

MorphoSys AG

May 2021 - February 2023

company logo

Vice President, Translational Medicine & Nonclinical Development at

Sunesis Pharmaceuticals, Inc.

November 2019 - January 2021

company logo

Executive Director, Translational Medicine at

Sunesis Pharmaceuticals, Inc.

March 2017 - November 2019

company logo

Senior Director, Translational Pharmacology at

Astex Pharmaceuticals, Inc. (US)

April 2014 - February 2017

company logo

Director Translational Pharmacology at

Astex Pharmaceuticals, Inc. (US)

June 2011 - April 2014

company logo

Assoc. Director, Translational Pharmacology at

Astex Pharmaceuticals, Inc. (US)

August 2008 - June 2011

company logo

Senior Scientist, Pharmacology at

Sunesis Pharmaceuticals, Inc.

July 2006 - August 2008

company logo

Principal Scientist, Pharmacology at

Chiron Corporation

March 2003 - July 2006

company logo

Scientist at

PANGENE CORPORATION

March 2001 - February 2003

Logos provided by Logo.dev

Pietro Taverna

Education

Case Western Reserve University, Research Associate Scientist

January 1997 - January 2001

Imperial Cancer Research Fund, London, UK, Postdoctoral Fellow

January 1992 - January 1995

Istituto Mario Negri, Milan, Italy, Pharmacological Research (Phd)

January 1990

University of Milan, Biological Sciences (Laurea)

January 1987

Frequently Asked Questions about Pietro Taverna

What is Pietro Taverna email address?

Pietro Taverna's primary email address is **************@constellationpharma.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Pietro Taverna work for?

Pietro Taverna is a Vice President Research & Translational Medicine at Karyopharm Therapeutics Inc., a company specializing in Biological products, except diagnostic.

Where Pietro Taverna graduated from?

Pietro Taverna holds a degree in from Case Western Reserve University.

How can I directly contact Pietro Taverna?

To contact Pietro Taverna directly, you can use the email address **************@constellationpharma.com. Complete contact information is available upon registration with Muraena.

Is Pietro Taverna an immigrant?

Yes, Pietro Taverna is an immigrant and currently based in United States

Who is Pietro Taverna?

Pietro Taverna is a distinguished Vice President of Research & Translational Medicine, with extensive expertise in the biopharmaceutical sector, particularly in oncology and translational research. He has a proven track record of leading cross-functional teams through all phases of drug development, from discovery to late-stage clinical trials. His collaborative approach has fostered significant partnerships within the academic and industrial landscapes, enhancing drug development processes. Pietro is highly regarded for his strategic insights in pharmacology and biomarker discovery, and has contributed to numerous publications in prestigious journals. His leadership has driven innovation in translational medicine, particularly in the development of therapies for hematologic malignancies. With a strong educational background in pharmacology, he combines scientific rigor with practical experience to advance therapeutic solutions. Beyond his professional achievements, he has received notable fellowships, underscoring his commitment to excellence in research.

Pietro`s contact details

mail

**************@constellationpharma.com

**************@astx.com

**************@karyopharm.com

Colleagues

avatar
Shijie Tang

Vice President, Data Sciences

Sohanya Cheng

Independent Board Director

Stephen Li

Lecturer, Graduate Program (Regulatory Affairs)

avatar
Steve Ferrari Ms

Vice President, Business Operations and Corporate Affairs

avatar
Andrew Johnson Md

Executive Director - Head of Medical Strategy Global Medical and Scientific Affairs

avatar
Andy Holton

Vice President of Market Access

avatar
Girish Gudi

Vice President, Clinical Pharmacology

Gretchen Smythe

Vice President, Program Lead - Oncology

avatar
Steve Kye

Vice President, Clinical Development - Myelofibrosis and MDS

Sunitha Reddy Nalla

Vice President, Regulatory Affairs

View Contact details (it's free)
Request Profile Removal